Jun 01, 2023 7:57am EDT Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference
May 03, 2023 8:26am EDT Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference
Mar 02, 2023 8:00am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting
Feb 23, 2023 8:00am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Feb 16, 2023 7:30am EST Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award
Jan 18, 2023 8:00am EST Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004
Dec 12, 2022 7:00am EST Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group
Dec 06, 2022 8:00am EST Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference
Nov 28, 2022 7:05pm EST Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9:00 AM Eastern Time
